Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iqvia Holdings Inc (NY: IQV ) 210.19 +1.03 (+0.49%) Official Closing Price Updated: 4:10 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Iqvia Holdings Inc < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > 10 Health Care Stocks With Whale Alerts In Today's Session July 01, 2024 Via Benzinga 5 Analysts Assess IQVIA Hldgs: What You Need To Know June 28, 2024 Via Benzinga IQVIA’s SmartSolve® eQMS Wins 2024 MedTech Breakthrough Award “Best Use of Artificial Intelligence in Healthcare” June 25, 2024 From IQVIA Via Business Wire IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites June 12, 2024 From IQVIA Via Business Wire Analyst Scoreboard: 4 Ratings For IQVIA Hldgs June 06, 2024 Via Benzinga (IQV) - Analyzing IQVIA Hldgs's Short Interest June 04, 2024 Via Benzinga Forecasting The Future: 8 Analyst Projections For IQVIA Hldgs May 03, 2024 Via Benzinga Peering Into IQVIA Hldgs's Recent Short Interest March 29, 2024 Via Benzinga IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses June 10, 2024 From IQVIA Via Business Wire AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades' June 07, 2024 AbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity Partners. Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session May 17, 2024 Via Benzinga U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute May 14, 2024 From IQVIA Via Business Wire Peering Into IQVIA Hldgs's Recent Short Interest March 13, 2024 Via Benzinga How Is The Market Feeling About IQVIA Hldgs? February 15, 2024 Via Benzinga IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024 May 09, 2024 From IQVIA Holdings Inc. Via Business Wire IQV Stock Earnings: IQVIA Hldgs Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 IQV stock results show that IQVIA Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace IQVIA Reports First-Quarter 2024 Results May 02, 2024 From IQVIA Holdings Inc. Via Business Wire Analysts Are Pounding the Table on These 3 Stocks: April 2024 May 01, 2024 From pharmaceutical testing to expansive integration expanding infrastructure, here are three stocks with analyst recommendations to buy. Via InvestorPlace IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards April 23, 2024 From IQVIA Via Business Wire IQVIA to Announce First-Quarter 2024 Results on May 2, 2024 April 15, 2024 From IQVIA Holdings Inc. Via Business Wire Salesforce & IQVIA Expand Partnership: Life Sciences Cloud Gets A Superpower Boost April 09, 2024 Salesforce shares rise after partnership with IQVIA to develop Life Sciences Cloud for customer engagement. Via Benzinga IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud April 08, 2024 From IQVIA Via Business Wire Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? March 17, 2024 Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while. Via The Motley Fool IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024 March 06, 2024 From IQVIA Holdings Inc. Via Business Wire IQVIA Publishes its 2023 Environmental, Social and Governance Report February 26, 2024 From IQVIA Via Business Wire Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report February 23, 2024 From IQVIA Via Business Wire IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024 February 21, 2024 From IQVIA Holdings Inc. Via Business Wire Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday? February 14, 2024 The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings. Via Benzinga Topics Economy Exposures Interest Rates Healthcare Analytics-Focused IQVIA Says 2023 Performance Solid Despite Challenging Macro Environment February 14, 2024 IQVIA beats Q4 2023 sales expectations, reporting $3.87 billion (3.5% Y/Y). Adjusted EPS of $2.84 exceeds guidance. IQV's 2023 performance and optimistic 2024 outlook. Via Benzinga Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday February 14, 2024 U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
